Qynapse Company
Qynapse leverages neuroimaging & AI to advance the accuracy and reliability of Central Nervous System diseases screening and monitoring.
Founded Date:
2015-01-01
Technology:
Artificial Intelligence, Clinical Trials, Health Care, Information Technology, Machine Learning, Medical, Neuroscience, Software
Funding Status:
Seed
Total Funding:
6600000
Employee Number:
11-50
Headquarters:
Paris, Ile-de-France, France
Last Funding Date:
2021-06-24
Investors Number:
1
Last Funding Type:
Seed
Estimated Revenue:
$1M to $10M
Acquisitions Number:
1
Industry:
Analytical Algoritms